Propanc Biopharma, Inc. (PPCB): Shareholders' Equity
$9.40M
As of 2026-06-30
$7.07M
As of 2026-09-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $9.40M | -32.4% | 2026-09-25, Balance as of period end |
| 2025-06-30 | $13.91M | n/m | 2026-09-25, Balance as of period end |
| 2024-06-30 | -$3.78M | n/m | 2025-09-29, Balance as of period end |
| 2023-06-30 | -$3.12M | n/m | 2024-09-30, Balance as of period end |
| 2022-06-30 | -$3.02M | n/m | 2023-09-28, Balance as of period end |
| 2021-06-30 | -$3.07M | n/m | 2022-09-28, Balance as of period end |
| 2020-06-30 | -$3.64M | n/m | 2021-09-28, Balance as of period end |
| 2019-06-30 | -$4.30M | n/m | 2020-10-01, Balance as of period end |
| 2018-06-30 | -$6.75M | n/m | 2019-10-15, Balance as of period end |
| 2017-06-30 | -$5.44M | n/m | 2018-09-17, Balance as of period end |
| 2016-06-30 | -$2.57M | n/m | 2017-09-28, Balance as of period end |
| 2015-06-30 | -$3.05M | n/m | 2016-09-28, Balance as of period end |
| 2014-06-30 | -$1.41M | n/m | 2015-09-30, Balance as of period end |
| 2013-06-30 | -$792.5K | n/m | 2014-10-14, Balance as of period end |
| 2012-06-30 | -$537.9K | n/m | 2013-10-15, Balance as of period end |
| 2011-06-30 | $10.51M | n/m | 2013-10-15, Balance as of period end |
| 2010-06-30 | -$186.9K | n/m | 2013-10-15, Balance as of period end |
| 2009-06-30 | -$409.4K | n/m | 2013-10-15, Balance as of period end |
| 2008-06-30 | $85.1K | n/a | 2013-10-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $9.40M | -32.4% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $9.66M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$15.94M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | $7.06M | +66.4% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $4.69M | n/m |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | $12.45M | +528.5% |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$6.64M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
Compare PPCB, NMAD, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗